Adil Daud, MD

Adil Daud, MD, is an HS Clinical Professor, Department of Medicine (Hematology/Oncology) at UCSF and Director, Melanoma Clinical Research at the UCSF Helen Diller Family Comprehensive Cancer Center. In addition to caring for patients, he directs research to better understand the biology of melanoma and to develop new treatments. He has developed and led many clinical trials that have expanded the use of gene therapy for melanoma. At UCSF, he co-directs the melanoma program and is the Principal Investigator of several early-phase and melanoma-specific clinical trials. He is particularly interested in investigating immunotherapy used in combination with PD-1 antibodies, as well as in understanding resistance to PD-1 – notably site-specific immunity.

Dr. Daud earned a medical degree at the Government Medical College, Nagpur. He completed both an internship and a residency in internal medicine at Indiana University School of Medicine, followed by a fellowship in hematology-oncology at Memorial Sloan Kettering Cancer Center. Prior to joining UCSF Medical Center, he was a researcher at the Moffitt Cancer Center in Tampa, Florida, for seven years.

Dr. Daud has won numerous awards, including a Young Investigator Award from the American Society of Clinical Oncology and selection as a Castle Connolly Top Doctor.